Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 9/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | FABP2 | P12104 | 1/20 | 0.55 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.55 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 2/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.49 |
| ▸ | HSD11B2 | P80365 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.49 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11377777 | 0.88 | PPARG (0.58) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL17859584 | 0.86 | HSD11B1 (0.46) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL9588829 | 0.86 | HSD11B1 (0.49) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL3845579 | 0.82 | PPARG (0.56) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL3526757 | 0.82 | PPARA (0.67) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL7991799 | 0.81 | OGG1 (0.55) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL9911068 | 0.81 | PPARG (0.55) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL7988206 | 0.81 | PPARA (0.55) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL21378829 | 0.81 | PPARG (0.74) | PPARACYP2C19MEN1CYP1A2CYP3A4 | |
| SCHEMBL11388366 | 0.81 | PPARG (0.74) | PPARACYP2C19MEN1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1217884-B1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2007-02-21 | — | — | EP | claimed |
| US-6897065-B1 | Method for maturation of conifer somatic embryos | WOODY PLANT BIOTECH APS (DK) | 2005-05-24 | — | — | US | claimed |
| EP-1217884-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | Woody Plant Biotech APS (DK) | 2002-07-03 | — | — | EP | claimed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | claimed |
| US-10118916-B2 | Modulators of cystic fibrosis transmembrane conductance regulator protein | ABBVIE S.Á.R.L. (LU) | 2018-11-06 | — | — | US | disclosed |
| WO-2017187321-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN | AbbVie S.à.r.l. (LU) | 2017-11-02 | — | — | WO | disclosed |
| US-20170305891-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN | ABBVIE S.Á.R.L. (LU) | 2017-10-26 | — | — | US | disclosed |
| CN-101300005-B | N-2 adamantyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors | JANSSEN PHARMACEUTICA NV | 2013-05-01 | — | — | CN | disclosed |
| US-8377923-B2 | Triazole derivative or salt thereof | ASTELLAS PHARMA INC. (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8377923-B2 | Triazole derivative or salt thereof | ASTELLAS PHARMA INC. (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8344181-B2 | Obesity, type 2 diabetes, hyperlipidemia, hypertension, arteriosclerosis, coronary heart diseases | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-01-01 | — | — | US | disclosed |
| EP-1575901-B1 | SUBSTITUTED AMIDES | MERCK SHARP & DOHME (US) | 2012-10-10 | — | — | EP | disclosed |
| US-6897065-B1 | Method for maturation of conifer somatic embryos | WOODY PLANT BIOTECH APS (DK) | 2005-05-24 | — | — | US | disclosed |
| EP-1496838-A2 | SUBSTITUTED AMIDES | Merck & Co., Inc. (US) | 2005-01-19 | — | — | EP | disclosed |
| WO-2004058145-A2 | SUBSTITUTED AMIDES | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| WO-2004048317-A1 | SUBSTITUTED AMIDES ACTIVE AT THE CANNABINOID-1 RECEPTOR | MERCK & CO., INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| US-20040058820-A1 | Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis | MERCK SHARP & DOHME LLC | 2004-03-25 | — | — | US | disclosed |
| WO-2003077847-A2 | SUBSTITUTED AMIDES | MERCK & CO., INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| EP-1217884-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | Woody Plant Biotech APS (DK) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305891-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN | CFTR, CHRM2, CHRM1 | PPARA 2278/4885CYP2C19 4157/4885MEN1 2068/4885 |
| US-20040058820-A1 | Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis | CNR1, CNR2, MAG | PPARA 780/4885CYP2C19 1058/4885MEN1 178/4885 |
| US-10118916-B2 | Modulators of cystic fibrosis transmembrane conductance regulator protein | CFTR, CHRM2, CHRM1 | PPARA 2278/4885CYP2C19 4157/4885MEN1 2068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.